Dr. David Russell, M.D., Ph.D
Claim this profileInstitute for Neurodegenerative Disorders
Studies Alzheimer's Disease
Studies Healthy Subjects
14 reported clinical trials
13 drugs studied
Area of expertise
1Alzheimer's Disease
APOE
ApoE positive
ApoE negative
2Healthy Subjects
Affiliated Hospitals
Clinical Trials David Russell, M.D., Ph.D is currently running
Donanemab
for Alzheimer's Disease
This trial is testing donanemab, a medication aimed at helping people with Alzheimer's Disease by removing harmful protein clumps from their brains. Donanemab has shown promise in reducing these harmful proteins in Alzheimer's disease.
Recruiting1 award Phase 34 criteria
[18F]APN-1607 PET Scan
for Progressive Supranuclear Palsy
The overall goal of this protocol is to evaluate \[18F\]APN-1607 as a PET radiotracer for measuring longitudinal change in tau pathology in participants with PSP.
Recruiting1 award Phase 15 criteria
More about David Russell, M.D., Ph.D
Clinical Trial Related3 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments David Russell, M.D., Ph.D has experience with
- Donanemab
- Placebo
- [18F]APN-1607
- Aducanumab
- [18F]MNI-444
- Amyvid
Breakdown of trials David Russell, M.D., Ph.D has run
Alzheimer's Disease
Healthy Subjects
Mild Cognitive Impairment
Cognitive Impairment
Parkinson's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Russell, M.D., Ph.D specialize in?
David Russell, M.D., Ph.D focuses on Alzheimer's Disease and Healthy Subjects. In particular, much of their work with Alzheimer's Disease has involved APOE patients, or patients who are ApoE positive.
Is David Russell, M.D., Ph.D currently recruiting for clinical trials?
Yes, David Russell, M.D., Ph.D is currently recruiting for 5 clinical trials in New Haven Connecticut. If you're interested in participating, you should apply.
Are there any treatments that David Russell, M.D., Ph.D has studied deeply?
Yes, David Russell, M.D., Ph.D has studied treatments such as Donanemab, Placebo, [18F]APN-1607.
What is the best way to schedule an appointment with David Russell, M.D., Ph.D?
Apply for one of the trials that David Russell, M.D., Ph.D is conducting.
What is the office address of David Russell, M.D., Ph.D?
The office of David Russell, M.D., Ph.D is located at: Institute for Neurodegenerative Disorders, New Haven, Connecticut 06510 United States. This is the address for their practice at the Institute for Neurodegenerative Disorders.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.